Ligand Pharmaceuticals Shares Rise 21% on 4Q Results Above Estimates : vimarsana.com

By Denny Jacob Ligand Pharmaceuticals shares were 21% higher at $89.98 following better-than-expected results in its fourth quarter. The stock is up about...

Related Keywords

Denny Jacob , Ligand Pharmaceuticals , Article Normal , Pharmaceuticals , Scientific Research Services , Healthcare Life Sciences , Business Consumer Services , Medical Research Services , Drug Discovery Development , Healthcare Support Services , Diagnostic Medical Research Services , Financial Performance , Share Price Movement Disruptions , Corporate Industrial News , Equity Markets , Commodity Financial Market News , Content Types , Factiva Filters , C Amp Ampe Exclusion Filter , C Amp Ampe Industry News Filter , Synd , Lgnd , Share Price Movement , Disruptions , Corporate , Industrial News , Commodity , Financial Market News , Healthcare , Life Sciences , Business , Consumer Services , Drug Discovery , Development , Diagnostic ,